Showing results (291-300 of 444) with videos related to
Sort By:
Pageof 45
Respiratory Medicine|November 20, 2020
Use of mucolytics in COPD: A Delphi consensus studyAlberto Papi, Sergey Avdeev, Peter M A Calverley, et al.The Lancet. Respiratory Medicine|March 15, 2020
Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trialIan D Pavord, Mark Holliday, Helen K Reddel, et al.Plos One|August 11, 2011
Immune response to Mycobacterium tuberculosis infection in the parietal pleura of patients with tuberculous pleurisyGaetano Caramori, Lisa Lasagna, Angelo G Casalini, et al.Respiratory Research|July 10, 2013
Neutrophil adhesion molecules in experimental rhinovirus infection in COPDPatrick Mallia, Simon D Message, Marco Contoli, et al.Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 22, 2026
Bone involvement in sarcoidosis: Insights from a multicentre Italian cohortTommaso Pianigiani, Elisa Bianchi, Giulio Natalello, et al.Journal of Inflammation (London, England)|August 6, 2016
Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot studyDonatella Poletti, Valeria Iannini, Paolo Casolari, et al.American Journal of Respiratory and Critical Care Medicine|August 16, 2008
IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary diseaseFiorella Calabrese, Simonetta Baraldo, Erica Bazzan, et al.Respiratory Medicine|November 8, 2016
Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and deviceP N Richard Dekhuijzen, Maria Batsiou, Leif Bjermer, et al.BMJ Open Respiratory Research|November 19, 2020
FN3K expression in COPD: a potential comorbidity factor for cardiovascular diseaseAmr Alderawi, Gaetano Caramori, Emma H Baker, et al.Pulmonary Therapy|June 23, 2026
Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled TrialsSurya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.Pageof 45